Default



Default

Home | Contact Us | Site Index | Search UW:

James D. Perkins, M.D.

 Jim Perkins photo

Patient Services:

Kidney and kidney / pancreas
Pre-transplant:
(206) 598-4819

Post-transplant:
(206) 598-1979

Living Kidney Donor Program
(206) 598-3627

Liver transplant
New patient scheduling:
(206) 598-4902

Post-transplant:
(206) 598-6658

Academic Office:

Phone: (206) 543-3825

E-mail:
theperk@u.washington.edu

Fax: (206) 543-8136

Address:
James D. Perkins, M.D.
University of Washington
Department of Surgery
Box 356410
Seattle, WA 98195-6410

Professor
Vice Chairman, Quality

Faculty Appointments:

University of Washington, Vice Chairman, Quality, Department of Surgery, 2004 - present.

University of Washington, Professor, 1996 - present.

University of Washington, Chief, Division of Transplantation, 1989 - 2004.

University of Washington, Associate Professor, 1989-96.

Mayo Medical School, Assistant Professor, 1988-89.

Mayo Medical School, Instructor in Surgery, 1986-88.

University of Utah, Instructor in Surgery, 1984-85.

VA Hospital, Salt Lake City, Instructor in Surgery, 1984.

Education:

Fellowships: University of Utah, 1984-85. Mayo Graduate School of Medicine, 1985.

Residency: University of Kansas, 1979-84.

M.D. Degree: University of Arkansas, 1979.

Board Certified: American College of Surgery, 1985. Recertified 1995, 2004.

Clinical Interests:

Kidney, liver and pancreas transplants, vascular access, and hepatobiliary surgery.

Research Interests:

  • Multi-stage variables or predictors of liver transplant outcomes.
  • Tolerance induction of allografts.

download Annual Research Report

Selected Publications:

Li W, Chou ST, Wang C, Kuhr CS, Perkins JD. Role of the liver in peripheral tolerance: Induction through oral antigen feeding. Am J Transplantation, 2004 Oct; 4(10):1574-82.

Perkins JD, Levy AE, Duncan JB, Carithers, RL. Using root cause analysis to improve survival in a liver transplant program. J Surg Res, 2005 Nov; 129(1):6-16.

Li W, Carper K, Perkins JD. Enhancement of NKT cells and increase in regulatory T cells results in improved allograft survival. J Surg Res, 2006 Jul;134(1):10-21.

Chan EY, Larson AM, Gernsheimer T, Kowdley K, Carithers RL, Reyes JD, Perkins JD.  Recipient and donor factors influence the incidence of graft-versus-host disease in liver transplant patients.  Liver Transpl, 2007 Apr 13(4):516-522.

Chan EY, Olson LC, Kisthard JA, Perkins JD, Bakthavatsalam R, Halldorson JB, Reyes JD, Larson AM, Levy AE.  Ischemic cholangiopathy following liver transplantation from donation after cardiac death donors.  Liver Transpl, 2008 May 14(5):604-610.

Chan EY, Larson AM, Fix OK, Yeh MM, Levy AE, Bakthavatsalam R, Halldorson JB, Reyes JD, Perkins JD.  Identifying risk for recurrent hepatocellular carcinoma after liver transplantation: implications for surveillance studies and new adjuvant therapies.  Liver Transpl, in press (2008).


reviewed 5/08